What Has Been The Evolution of the Embolotherapy Market in Recent Years?
The embolotherapy market has seen considerable growth due to a variety of factors.
• There has been notable growth in the embolotherapy market size in previous years. The market which is projected to evolve from $4.44 billion in 2024 will increase to $4.86 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.3%.
The past growth of this market is a response to several factors, such as the escalating requirement for embolotherapy for treatment scenarios, the growing prevalence of cancer, the rise in cases of peripheral vascular diseases, heightened expenditure on healthcare, and amplified investments devoted to research.
How Will the Embolotherapy Market?
The embolotherapy market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the embolotherapy market to experience robust growth in the upcoming years, projected to reach $6.83 billion by 2029, with a compound annual growth rate (CAGR) of 8.9%.
Factors contributing to this forecasted growth range from an increase in disposable income and a rise in chronic diseases, to wider acceptance in reproductive health, a growing number of cheoembolization procedures, and an increased occurrence of liver cancer. The forecast period is likely to witness significant trends, including advanced technologies, a mix of digital and analog devices, an implantable heart monitor, embolotherapy techniques, and strategic partnerships.
Which Factors Are Boosting Growth In The Embolotherapy Market?
An upward trend in the favourability of minimally invasive procedures is anticipated to fuel the expansion of the embolotherapy market. The term minimally invasive procedures describes cosmetic treatments that need little or no surgical involvement, generally involving less downtime and fewer risks. The increasing liking for these procedures is sped up by faster recuperation, diminished pain, less significant scars, reduced risk of complications, and advancements in technology. Embolotherapy improves these procedures by selectively obstructing blood flow to specific vessels, minimizing bleeding, addressing tumors, and controlling vascular abnormalities with more accuracy and fewer complications. As an example, in September 2023, the American Society of Plastic Surgeons, a not-for-profit organization based in the US, reported a 7% growth in cosmetic minimally invasive procedures in 2023, amounting to 25,442,640, a rise from 23,672,269 in 2022. Consequently, the growing liking for minimally invasive procedures is propelling the expansion of the embolotherapy market.
What Key Areas Define The Segmentation Of The Global Embolotherapy Market?
The embolotherapy market covered in this report is segmented –
1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices
2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders
3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)
4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users
Subsegments:
1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils
2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles
3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons
4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems
5) By Support Devices: Guidewires, Catheters, Sheath Introducers
Pre-Book The Embolotherapy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Embolotherapy Market?
The focus of key players in the embolotherapy industry is on the innovation of products like absorbable embolic systems, aimed at improving patient results and broadening treatment alternatives. Absorbable embolic systems are biodegradable materials that are used in embolization processes to block the blood flow to specific tissues, including tumors and aneurysms, while slowly deteriorating within the body. For instance, in January 2025, Instylla Inc., a medical equipment producer based in the U.S., secured FDA 510(k) approval for its Tembo embolic system, a biodegradable embolization agent consisting of irregular-shaped, dry-gelatin particles, varying from 85 to 255 µm in size. This system is developed for embolizing hypervascular tumors and obstructing blood vessels in the peripheral vasculature. As per Instylla, Tembo provides benefits like swift preparation, excellent visibility, and the capacity to pack treated vessels densely, thereby potentially enhancing pre-existing permanent embolic solutions.
Who Are the Key Players In The Embolotherapy Market?
Major companies operating in the embolotherapy market are:
• Boston Scientific Corporation
• Terumo Medical Corporation
• Medtronic PLC
• Johnson And Johnson
• Stryker Corporation
• Sirtex Medical
• Abbott Laboratories
• Acandis GmbH
• Balt Group LLC
• Penumbra Inc
• Merit Medical Systems
• Kaneka Corporation
• Meril Life Sciences Pvt. Ltd.
• Shape Memory Medical Inc
• Guerbet
• IMBiotechnologies Ltd
• Cardiva
• Rapid Medical
• Emboline Inc
• Microport Scientific
• Inari Medical
• Instylla Inc
• Embolx Inc
• GE Healthcare
• Lepu Medical Technology Co Ltd
• WEGO HEALTHCARE (SHENZHEN) CO.
• LTD
• Achieva Medical Inc
• Varian Medical Syatems Inc
What Is The Most Dominant Region In The Embolotherapy Market?
North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
